XL Axiata Tbk. vs Indofarma Tbk. — how do they compare? XL Axiata Tbk. trades at Rp2,630 (market cap 49.14T, 6.84M 24h volume), while Indofarma Tbk. trades at Rp126 (market cap 390.51B). The key difference: XL Axiata Tbk. is far larger — about 125.8× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.
| EXCL | INAF | |
|---|---|---|
Market Cap | 49.14T | 390.51B |
Volume | 6.84M | — |
Lot | 68.44K | — |
Turnover | 18.12B | — |
Average Price | 2,647.02 | — |
Value | 18.12B | — |
Indicative Equilibrium Price | 2,630 | — |
Indicative Equilibrium Volume | 2.22K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT XL Axiata Tbk (the Company) which was previously known as PT Excelcomindo Pratama Tbk, was initially established under the name PT Grahametropolitan Lestari. The Company was established on Oct 6th, 1989.The articles of association have been amended several times, most recently on Aug 2, 2005, concerning among other the change of par value, equity and public offering. The company started its operation since October 1996 and was the 3rd biggest company in Indonesia for the number of customer and income.
Read more on EXCL →PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →